120 related articles for article (PubMed ID: 35193825)
1. Safety of sibling cord blood cell infusion for children with cerebral palsy.
Crompton K; Novak I; Fahey M; Badawi N; Lee KJ; Mechinaud-Heloury F; Edwards P; Colditz P; Soosay Raj T; Hough J; Wang X; Paget S; Hsiao KC; Anderson P; Reddihough D
Cytotherapy; 2022 Sep; 24(9):931-939. PubMed ID: 35193825
[TBL] [Abstract][Full Text] [Related]
2. Single group multisite safety trial of sibling cord blood cell infusion to children with cerebral palsy: study protocol and rationale.
Crompton K; Novak I; Fahey M; Badawi N; Wallace E; Lee K; Mechinaud-Heloury F; Colditz PB; Elwood N; Edwards P; Reddihough D
BMJ Open; 2020 Mar; 10(3):e034974. PubMed ID: 32152173
[TBL] [Abstract][Full Text] [Related]
3. Effect of Autologous Cord Blood Infusion on Motor Function and Brain Connectivity in Young Children with Cerebral Palsy: A Randomized, Placebo-Controlled Trial.
Sun JM; Song AW; Case LE; Mikati MA; Gustafson KE; Simmons R; Goldstein R; Petry J; McLaughlin C; Waters-Pick B; Chen LW; Wease S; Blackwell B; Worley G; Troy J; Kurtzberg J
Stem Cells Transl Med; 2017 Dec; 6(12):2071-2078. PubMed ID: 29080265
[TBL] [Abstract][Full Text] [Related]
4. Sibling umbilical cord blood infusion is safe in young children with cerebral palsy.
Sun JM; Case LE; Mikati MA; M Jasien J; McLaughlin C; Waters-Pick B; Worley G; Troy J; Kurtzberg J
Stem Cells Transl Med; 2021 Sep; 10(9):1258-1265. PubMed ID: 34085782
[TBL] [Abstract][Full Text] [Related]
5. Motor function and safety after allogeneic cord blood and cord tissue-derived mesenchymal stromal cells in cerebral palsy: An open-label, randomized trial.
Sun JM; Case LE; McLaughlin C; Burgess A; Skergan N; Crane S; Jasien JM; Mikati MA; Troy J; Kurtzberg J
Dev Med Child Neurol; 2022 Dec; 64(12):1477-1486. PubMed ID: 35811372
[TBL] [Abstract][Full Text] [Related]
6. A Randomized, Placebo-Controlled Trial of Human Umbilical Cord Blood Mesenchymal Stem Cell Infusion for Children With Cerebral Palsy.
Huang L; Zhang C; Gu J; Wu W; Shen Z; Zhou X; Lu H
Cell Transplant; 2018 Feb; 27(2):325-334. PubMed ID: 29637820
[TBL] [Abstract][Full Text] [Related]
7. Safety and feasibility of autologous cord blood infusion for improving motor function in young children with cerebral palsy in Japan: A single-center study.
Kikuchi H; Saitoh S; Tsuno T; Hosoda R; Baba N; Wang F; Mitsuda N; Tsuda M; Maeda N; Sagara Y; Fujieda M
Brain Dev; 2022 Nov; 44(10):681-689. PubMed ID: 36050140
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial.
Zarrabi M; Akbari MG; Amanat M; Majmaa A; Moaiedi AR; Montazerlotfelahi H; Nouri M; Hamidieh AA; Badv RS; Karimi H; Rabbani A; Mohebbi A; Rahimi-Dehgolan S; Rahimi R; Dehghan E; Vosough M; Abroun S; Shamsabadi FM; Tavasoli AR; Alizadeh H; Pak N; Zamani GR; Mohammadi M; Javadzadeh M; Ghofrani M; Hassanpour SH; Heidari M; Taghdiri MM; Mohseni MJ; Noparast Z; Masoomi S; Goudarzi M; Mohamadpour M; Shodjaee R; Samimi S; Mohammad M; Gholami M; Vafaei N; Koochakzadeh L; Valizadeh A; Malamiri RA; Ashrafi MR
BMC Neurol; 2022 Mar; 22(1):123. PubMed ID: 35351020
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of the synergistic effects of cord blood cells and erythropoietin combination therapy after additional cord blood infusion in children with cerebral palsy: 1-year open-label extension study of randomized placebo-controlled trial.
Suh MR; Min K; Cho KH; Kim J; Lim I; Park M; Noh EM; Kim MY
Stem Cell Res Ther; 2023 Dec; 14(1):362. PubMed ID: 38087394
[TBL] [Abstract][Full Text] [Related]
10. Umbilical Cord Blood Cell Clearance Post-Infusion in Immune-Competent Children with Cerebral Palsy.
Crompton K; Godler DE; Ling L; Elwood N; Mechinaud-Heloury F; Soosay Raj T; Hsiao KC; Fleming J; Tiedemann K; Novak I; Fahey M; Wang X; Lee KJ; Colditz PB; Edwards P; Reddihough D
Cells Tissues Organs; 2023; 212(6):546-553. PubMed ID: 36261026
[TBL] [Abstract][Full Text] [Related]
11. Human allogeneic AB0/Rh-identical umbilical cord blood cells in the treatment of juvenile patients with cerebral palsy.
Romanov YA; Tarakanov OP; Radaev SM; Dugina TN; Ryaskina SS; Darevskaya AN; Morozova YV; Khachatryan WA; Lebedev KE; Zotova NS; Burkova AS; Sukhikh GT; Smirnov VN
Cytotherapy; 2015 Jul; 17(7):969-78. PubMed ID: 25791070
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of trialling cord blood stem cell treatments for cerebral palsy in Australia.
Crompton KE; Elwood N; Kirkland M; Clark P; Novak I; Reddihough D
J Paediatr Child Health; 2014 Jul; 50(7):540-4. PubMed ID: 24909743
[TBL] [Abstract][Full Text] [Related]
13. Clinical and imaging outcomes after intrathecal injection of umbilical cord tissue mesenchymal stem cells in cerebral palsy: a randomized double-blind sham-controlled clinical trial.
Amanat M; Majmaa A; Zarrabi M; Nouri M; Akbari MG; Moaiedi AR; Ghaemi O; Zamani F; Najafi S; Badv RS; Vosough M; Hamidieh AA; Salehi M; Montazerlotfelahi H; Tavasoli AR; Heidari M; Mohebi H; Fatemi A; Garakani A; Ashrafi MR
Stem Cell Res Ther; 2021 Aug; 12(1):439. PubMed ID: 34362453
[TBL] [Abstract][Full Text] [Related]
14. Improvement in gross motor function and muscle tone in children with cerebral palsy related to neonatal icterus: an open-label, uncontrolled clinical trial.
Thanh LN; Trung KN; Duy CV; Van DN; Hoang PN; Phuong ANT; Ngo MD; Thi TN; Viet AB
BMC Pediatr; 2019 Aug; 19(1):290. PubMed ID: 31438885
[TBL] [Abstract][Full Text] [Related]
15. The effects of bone marrow mononuclear cell transplantation on the quality of life of children with cerebral palsy.
Nguyen TL; Nguyen HP; Nguyen TK
Health Qual Life Outcomes; 2018 Aug; 16(1):164. PubMed ID: 30107811
[TBL] [Abstract][Full Text] [Related]
16. Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial.
Min K; Song J; Kang JY; Ko J; Ryu JS; Kang MS; Jang SJ; Kim SH; Oh D; Kim MK; Kim SS; Kim M
Stem Cells; 2013 Mar; 31(3):581-91. PubMed ID: 23281216
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of GMFM-88 and GMFM-66 to detect changes in gross motor function in children with cerebral palsy (CP): a literature review.
Alotaibi M; Long T; Kennedy E; Bavishi S
Disabil Rehabil; 2014; 36(8):617-27. PubMed ID: 23802141
[TBL] [Abstract][Full Text] [Related]
18. Safety and feasibility of countering neurological impairment by intravenous administration of autologous cord blood in cerebral palsy.
Lee YH; Choi KV; Moon JH; Jun HJ; Kang HR; Oh SI; Kim HS; Um JS; Kim MJ; Choi YY; Lee YJ; Kim HJ; Lee JH; Son SM; Choi SJ; Oh W; Yang YS
J Transl Med; 2012 Mar; 10():58. PubMed ID: 22443810
[TBL] [Abstract][Full Text] [Related]
19. Gross Motor Function Measure Evolution Ratio: Use as a Control for Natural Progression in Cerebral Palsy.
Marois P; Marois M; Pouliot-Laforte A; Vanasse M; Lambert J; Ballaz L
Arch Phys Med Rehabil; 2016 May; 97(5):807-814.e2. PubMed ID: 26292263
[TBL] [Abstract][Full Text] [Related]
20. Effects of bone marrow mesenchymal stromal cells on gross motor function measure scores of children with cerebral palsy: a preliminary clinical study.
Wang X; Cheng H; Hua R; Yang J; Dai G; Zhang Z; Wang R; Qin C; An Y
Cytotherapy; 2013 Dec; 15(12):1549-62. PubMed ID: 24100132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
